Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
- Resource Type
- Article
- Source
- In
Blood Advances 25 July 2023 7(14):3739-3748 - Subject
Clinical Trials and Observations Lymphoid Neoplasia - Language
- ISSN
- 2473-9529